SlideShare a Scribd company logo
1 of 22
Download to read offline
State of Play: Implementation of SPOCs –
European Directorate for the Quality of
Medicines & HealthCare (EDQM)/Council of
Europe
APEC Life Sciences Innovation Forum (LSIF) Training Program on Medical
Product Integrity and Supply Chain Security
Establishment of Global Single Point of Contact Systems-
28 January 2015, Clark (Angeles City), the Philippines
Dr François-Xavier Lery, EDQM/Council of Europe
Council of Europe
Inter-governmental
organisation
Core values:
• human rights
• pluralist democracy
• rule of law
Distinct from European Union
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
European Directorate for the Quality of
Medicines & HealthCare (EDQM)
Council of Europe
Directorate
Convention on the
Elaboration of a
European
Pharmacopoeia
(1964)
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Council of Europe/EDQM
Specific platform for cooperation against counterfeit/falsified
medical products:
• Human Rights & Rule of Law
• Minimising public health risks posed by counterfeit medical
products & similar crimes
Supported at the level of the EDQM by:
Committee of Experts on Minimising public health risks posed by
counterfeit medical products & similar crimes (expert & policy-
making levels): CD-P-PH/CMED
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
CD-P-PH/CMED
Support of promotion and application of the MEDICRIME
convention by a comprehensive & integrated approach:
• Support for the development of specific legislation
• Multisectorial cooperation (EDQM training platform) &
intelligence building→ SPOCs
• Public health protection: awareness, risk communication,
identification of health damage in patients
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Drafted & presented: 2nd Workshop 22-23 May 2013, Seoul:
EDQM, Lead, APEC RHSC Roadmap Working Group SPOC; inspired by Council of Europe SPOCs Model
International
Co-operation
between
National
SPOCs
National SPOC
Role in international and
national co-operation
Central Reporting Point
Industry
Investigation SPOC e.g.
Qualified/Responsible
Person
SPOC for
Customs
SPOC for
Police
SPOC for
Justice
SPOC for
Medicines
Regulatory
Authority (DRA)
incl. Official
Medicines Control
Laboratories
Competent
Authorities for
Medical Devices
national network
SPOC
Formal or informal collaboration
between SPOCs at national level
Signals
Public; health
professionals
Overview: APEC SPOCs Tool Kit (1)
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Overview of APEC SPOCs Tool Kit (2)
→ Scope: Medical products produced, marketed, advertised
outside the regulatory control of the competent
authorities (WHO SSFFC): criminal investigations on
counterfeit/falsified medical products
→ Public health protection should be a priority
→ Cooperative approach:
• A. National SPOC (one per state/economy)
• B. SPOCs within competent authorities (a SPOC per competent
authority in each state/economy)
• Industry Investigation SPOC liaison/cooperation with A.,B.
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Overview of APEC SPOCs Tool Kit (3)
A. National SPOC – Central Reporting Point in one
state/economy
→ Centralises information held by competent authorities
within one state/economy about medical products
produced, marketed, advertised outside the regulatory
control of the competent authorities
→ Information is disseminated to National SPOCs of other
states/economies for international cooperation
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Overview of APEC SPOCs Tool Kit (4)
B. SPOCs -police, customs, health authorities incl.
official laboratories, judiciary- within one
state/economy
→ Regular/systematic networking: law, agreement-based or
informal
→ Operational management: « signals » (suspect cases) or
confirmed cases
→ National authorities to decide on modes of investigation
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
APEC–EDQM/Council of Europe common goals
(SPOCs) – common approaches (1)
APEC LSIF Anti-counterfeit Medicines Action Plan Components –
Council of Europe Model for a Network between SPOCs:
1. ...Cooperation within each APEC economy/states (regulators, customs,
law enforcement, judicial and industry) critical…
2. APEC economies/states to work together to collect data on counterfeit
medicines
3. APEC economies/states to coordinate legislation, penalties for
prosecuting criminals counterfeiting medicines posing a threat to public
health; bypassing regulatory control
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
APEC–EDQM/Council of Europe common goals
(SPOCs) – common approaches (2)
→ Council of Europe SPOCs model: adopted June 2007
→ European Union Regulatory Authorities (Working Party
Enforcement Officers): endorsed September 2007
→ Permanent Forum International Pharmaceutical Crime;
tabled at WHO IMPACT endorsed December 2007 for
international use
→ APEC Anti-counterfeit Medicines Action Plan: endorsed
September 2010 (SPOCs: see previous slide)
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
APEC–EDQM/Council of Europe common goals
(SPOCs) – common approaches (3)
→ Legal provisions for national/international cooperation
among competent authorities: Council of Europe
MEDICRIME Convention, international treaty: opened
October 2011 for states to join
→ 2nd APEC LSIF Action Plan Workshop Seoul (Korea) May
2013: supported APEC SPOC Tool Kit
→ Agreed: development of National SPOC (within 12 months
of APEC LSF and RHSC endorsement)
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
State of Play: Implementation of SPOCs
EDQM basic training
Aims:
→ raise awareness
→ foster co-operation
→ share knowledge & best
practices – SPOCs model
→ in national teams
(medical products regulators
+ police + customs)
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Activities:
→ delivery of training to nominees of
authorities
→ trainers: delegates of Council of
Europe bodies;
→ “train the trainers” approach:
subsequent roll-out
→ evaluation: trainees’ feed-back –
consideration in further basic/
advanced level training
→ follow up: immediately;
impact 3 and 6 months after training
State of Play: Implementation of SPOCs
EDQM basic training
Results: 2007 – ongoing
National teams of 40 states in Europe; 6 States (Africa; South-America):
200 officials
EDQM training platform
Establishing/maintaining a network of SPOCs:
Aims:
Nomination/appointment/designation by national authorities:
National SPOCs, authority SPOCs within 47 member states of Council of
Europe
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
State of Play: Implementation of SPOCs –
EDQM SPOC network
Activities:
National competent authorities notified (S)POCs or equivalents to the
EDQM (2013)
Results:
National SPOCs, authority SPOCs (100):
Regulatory, police, customs authorities;
contact details, competencies, validity of authorisation
EDQM to maintain list (based on procedure)
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
State of Play: Implementation of SPOCs –
EDQM Advanced level SPOCs training
Aim:
→ Knowledge, skills: to establish a SPOCs network and to co-operate across
the region
→ Use of practical tools for SPOCs co-operation
→ Forum for exchange of expertise and experience
Activities development:
→ Tracking sheets
→ Signal management procedures
→ Tools for information exchange
Results: 2012 - ongoing
National teams of 12 states (Europe); 4 States (Africa): 90 officials
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
State of Play: Implementation of SPOCs –
EDQM KnowX database
Knowledge database: inventory of experiences with confirmed
cases
Aim:
→ Platform for officials from competent authorities to build knowledge and
intelligence (restricted access)
→ Help SPOCs report and share information
→ Use/access for SPOCs/equivalent officials: under participating authorities’
control
Activities:
→ EDQM: technical development and host of the database
Results:
→ Database launched: March 2014
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Legal provisions:
Interagency cooperation (S)POCs
Convention on the counterfeiting of medical products and
similar crimes involving threats to public health (Council of
Europe international treaty; treaty series 211): MEDICRIME
Goal:
→ Prevent and combat above acts through a harmonised international legal
framework, perspective of public health protection
Objectives:
→ Protection of public health through criminalising acts threatening patient
health
→ Patient protection
→ Promotion of cooperation among competent health and law enforcement
authorities within each state + on international level
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Legal provisions:
Interagency cooperation (S)POCs
MEDICRIME
Specific provisions supporting cooperation among authorities:
→ Art 17. National measures of coordination, collaboration and information
exchange:
• … to ensure that national competent authorities exchange information and
cooperate to prevent and combat…through points of contact
• …receiving and collecting data
→ Art 22. International co-operation on prevention and other administrative
measures:
• …designate a national contact point …transmitting and receiving requests
for information and/or cooperation with the fight against counterfeiting of
medical products and similar crimes involving threats to public health….
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Follow-up
Upon LIF and RHC endorsement of SPOCs toolkit (2013):
→ APEC economies: status update of development of a SPOC system within
their economy
→ APEC Gap analysis: a) operational SPOCs, b) SPOCs in development,
c) planned SPOC development, d) no planned SPOCs
→ Establishment of APEC SPOC database – assistance offered:
• INTERPOL (May 2013 SPOC workshop);
• EDQM (CoE) particularly in APEC economies that are Council of Europe
members, observers and observers European Pharmacopoeia Commission
• Complementing SPOCs in Europe
→ Planning a follow-up SPOC APEC workshop during 2015:
• expertise from APEC economies with operational SPOCs, WHO, EDQM and
Interpol.
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Conclusion
 Networking across borders only effective if based on
common concepts, understanding and working methods:
harmonised SPOCs approach – APEC 1/3/21, international
community
 EDQM (Council of Europe) welcomes global international
cooperation
 Criminals are networkers – let’s do better!
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
Thank-you for your attention!
For more information: www.coe.int; www.edqm.eu
22
Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.

More Related Content

What's hot

Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...Manukonda sravani Reddy
 
C5 Export Controls 10 & 11 March 2009 Final London
C5 Export Controls 10 & 11 March 2009 Final LondonC5 Export Controls 10 & 11 March 2009 Final London
C5 Export Controls 10 & 11 March 2009 Final Londonjasperhelder
 
EU Regulatory Approach to GM Foods
EU Regulatory Approach to GM Foods EU Regulatory Approach to GM Foods
EU Regulatory Approach to GM Foods Ksenia Petrovets
 
ECDC and early detection of public health threats of EU concern: the role of ...
ECDC and early detection of public health threats of EU concern: the role of ...ECDC and early detection of public health threats of EU concern: the role of ...
ECDC and early detection of public health threats of EU concern: the role of ...Global Risk Forum GRFDavos
 
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]cmid
 
Novel foods for Vitafoods
Novel foods for VitafoodsNovel foods for Vitafoods
Novel foods for VitafoodsAxon Lawyers
 
Medical literature monitoring and entering negative reaction reports
Medical literature monitoring and entering negative reaction reportsMedical literature monitoring and entering negative reaction reports
Medical literature monitoring and entering negative reaction reportsPEPGRA Healthcare
 
Vaccine Security meeting - Impact and opportunities for the new EU regulation...
Vaccine Security meeting - Impact and opportunities for the new EU regulation...Vaccine Security meeting - Impact and opportunities for the new EU regulation...
Vaccine Security meeting - Impact and opportunities for the new EU regulation...EuFMD
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union ShantanuThakre3
 
Vitafoods marketing functional food to children
Vitafoods marketing functional food to childrenVitafoods marketing functional food to children
Vitafoods marketing functional food to childrenAxon Lawyers
 
Vitafoods eu clinical trials regulation
Vitafoods   eu clinical trials regulationVitafoods   eu clinical trials regulation
Vitafoods eu clinical trials regulationAxon Lawyers
 
Berkeley Class 2009 Final
Berkeley Class 2009   FinalBerkeley Class 2009   Final
Berkeley Class 2009 FinalKlaus Berend
 
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...THL
 
Vitafoods - Alternative Sources of Protein
Vitafoods - Alternative Sources of Protein Vitafoods - Alternative Sources of Protein
Vitafoods - Alternative Sources of Protein Axon Lawyers
 
Vitafoods B2C communication in the funtional food
 Vitafoods B2C communication in the funtional food  Vitafoods B2C communication in the funtional food
Vitafoods B2C communication in the funtional food Axon Lawyers
 
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...THL
 
Vitafoods Europe 2015: Clearer labels for consumers
Vitafoods Europe 2015: Clearer labels for consumersVitafoods Europe 2015: Clearer labels for consumers
Vitafoods Europe 2015: Clearer labels for consumersAxon Lawyers
 

What's hot (20)

Session 25 antoni_montserrat
Session 25 antoni_montserratSession 25 antoni_montserrat
Session 25 antoni_montserrat
 
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
 
Antoni Montserrat
Antoni MontserratAntoni Montserrat
Antoni Montserrat
 
25 pharmaceuticals
25 pharmaceuticals25 pharmaceuticals
25 pharmaceuticals
 
C5 Export Controls 10 & 11 March 2009 Final London
C5 Export Controls 10 & 11 March 2009 Final LondonC5 Export Controls 10 & 11 March 2009 Final London
C5 Export Controls 10 & 11 March 2009 Final London
 
EU Regulatory Approach to GM Foods
EU Regulatory Approach to GM Foods EU Regulatory Approach to GM Foods
EU Regulatory Approach to GM Foods
 
ECDC and early detection of public health threats of EU concern: the role of ...
ECDC and early detection of public health threats of EU concern: the role of ...ECDC and early detection of public health threats of EU concern: the role of ...
ECDC and early detection of public health threats of EU concern: the role of ...
 
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
 
Novel foods for Vitafoods
Novel foods for VitafoodsNovel foods for Vitafoods
Novel foods for Vitafoods
 
Medical literature monitoring and entering negative reaction reports
Medical literature monitoring and entering negative reaction reportsMedical literature monitoring and entering negative reaction reports
Medical literature monitoring and entering negative reaction reports
 
Vaccine Security meeting - Impact and opportunities for the new EU regulation...
Vaccine Security meeting - Impact and opportunities for the new EU regulation...Vaccine Security meeting - Impact and opportunities for the new EU regulation...
Vaccine Security meeting - Impact and opportunities for the new EU regulation...
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union
 
Vitafoods marketing functional food to children
Vitafoods marketing functional food to childrenVitafoods marketing functional food to children
Vitafoods marketing functional food to children
 
Vitafoods eu clinical trials regulation
Vitafoods   eu clinical trials regulationVitafoods   eu clinical trials regulation
Vitafoods eu clinical trials regulation
 
Berkeley Class 2009 Final
Berkeley Class 2009   FinalBerkeley Class 2009   Final
Berkeley Class 2009 Final
 
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
 
Vitafoods - Alternative Sources of Protein
Vitafoods - Alternative Sources of Protein Vitafoods - Alternative Sources of Protein
Vitafoods - Alternative Sources of Protein
 
Vitafoods B2C communication in the funtional food
 Vitafoods B2C communication in the funtional food  Vitafoods B2C communication in the funtional food
Vitafoods B2C communication in the funtional food
 
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
 
Vitafoods Europe 2015: Clearer labels for consumers
Vitafoods Europe 2015: Clearer labels for consumersVitafoods Europe 2015: Clearer labels for consumers
Vitafoods Europe 2015: Clearer labels for consumers
 

Viewers also liked

TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?TGA Australia
 
Developments in regulatory requirements
Developments in regulatory requirements Developments in regulatory requirements
Developments in regulatory requirements Tim Sandle, Ph.D.
 
EDQM - Overview of our products and services (2016)
EDQM - Overview of our products and services (2016)EDQM - Overview of our products and services (2016)
EDQM - Overview of our products and services (2016)Council of Europe (CoE)
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYdatchayani
 
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...Council of Europe (CoE)
 
Monograph devlopement manish
Monograph devlopement manishMonograph devlopement manish
Monograph devlopement manishManish Mudaliar
 
I.p. 2007 volume 1
I.p. 2007 volume 1I.p. 2007 volume 1
I.p. 2007 volume 1Rahul Pandit
 
Pharmacopoeias
PharmacopoeiasPharmacopoeias
PharmacopoeiasAmol Patil
 

Viewers also liked (11)

Epre
EpreEpre
Epre
 
TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?
 
Developments in regulatory requirements
Developments in regulatory requirements Developments in regulatory requirements
Developments in regulatory requirements
 
EDQM - Overview of our products and services (2016)
EDQM - Overview of our products and services (2016)EDQM - Overview of our products and services (2016)
EDQM - Overview of our products and services (2016)
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
 
European pharmacopoeia
European pharmacopoeiaEuropean pharmacopoeia
European pharmacopoeia
 
Monograph devlopement manish
Monograph devlopement manishMonograph devlopement manish
Monograph devlopement manish
 
I.p. 2007 volume 1
I.p. 2007 volume 1I.p. 2007 volume 1
I.p. 2007 volume 1
 
Pharmacopoeias
PharmacopoeiasPharmacopoeias
Pharmacopoeias
 
Pharmacopoeia
PharmacopoeiaPharmacopoeia
Pharmacopoeia
 

Similar to 150128 APEC Clark SPOCs

Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceDutch Orphan Drug Network
 
Creating collaborative systems to address orphan drugs in a sustainable way –...
Creating collaborative systems to address orphan drugs in a sustainable way –...Creating collaborative systems to address orphan drugs in a sustainable way –...
Creating collaborative systems to address orphan drugs in a sustainable way –...Dutch Orphan Drug Network
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxReshmaManeDeshmukh
 
Pharmacovigilance_ Dr Ruchi Kushwaha.pptx
Pharmacovigilance_ Dr Ruchi Kushwaha.pptxPharmacovigilance_ Dr Ruchi Kushwaha.pptx
Pharmacovigilance_ Dr Ruchi Kushwaha.pptxDr Ruchi Kushwaha
 
WHO International Drug Monitoring Program
WHO International Drug Monitoring ProgramWHO International Drug Monitoring Program
WHO International Drug Monitoring ProgramSnehaKhandale1
 
European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesPlan de Calidad para el SNS
 
Minimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance systemMinimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance systemPriti Gupta
 
REGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptxREGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptxShivamKumar740
 
Regulatory requirement for europe union
Regulatory requirement for europe unionRegulatory requirement for europe union
Regulatory requirement for europe unionShresthaPandey1
 
Current regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank LievensCurrent regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank LievensApollo Hospitals Group and ATNF
 

Similar to 150128 APEC Clark SPOCs (20)

Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
 
150129 APEC Clark SPOCs
150129 APEC Clark SPOCs150129 APEC Clark SPOCs
150129 APEC Clark SPOCs
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task Force
 
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
 
141203_MS_pharma_regulation
141203_MS_pharma_regulation141203_MS_pharma_regulation
141203_MS_pharma_regulation
 
Creating collaborative systems to address orphan drugs in a sustainable way –...
Creating collaborative systems to address orphan drugs in a sustainable way –...Creating collaborative systems to address orphan drugs in a sustainable way –...
Creating collaborative systems to address orphan drugs in a sustainable way –...
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
 
Pharmacovigilance_ Dr Ruchi Kushwaha.pptx
Pharmacovigilance_ Dr Ruchi Kushwaha.pptxPharmacovigilance_ Dr Ruchi Kushwaha.pptx
Pharmacovigilance_ Dr Ruchi Kushwaha.pptx
 
Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)
 
Session 2 terkel_andersen
Session 2 terkel_andersenSession 2 terkel_andersen
Session 2 terkel_andersen
 
Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...
 
Dgi slideshare 2014-05-06_en
Dgi slideshare 2014-05-06_enDgi slideshare 2014-05-06_en
Dgi slideshare 2014-05-06_en
 
WHO International Drug Monitoring Program
WHO International Drug Monitoring ProgramWHO International Drug Monitoring Program
WHO International Drug Monitoring Program
 
European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare Diseases
 
Minimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance systemMinimum requirements for a functional pharmacovigilance system
Minimum requirements for a functional pharmacovigilance system
 
An introduction to the EMA
An introduction to the EMAAn introduction to the EMA
An introduction to the EMA
 
REGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptxREGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptx
 
Regulatory requirement for europe union
Regulatory requirement for europe unionRegulatory requirement for europe union
Regulatory requirement for europe union
 
Josée hansen igz
Josée hansen   igzJosée hansen   igz
Josée hansen igz
 
Current regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank LievensCurrent regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank Lievens
 

150128 APEC Clark SPOCs

  • 1. State of Play: Implementation of SPOCs – European Directorate for the Quality of Medicines & HealthCare (EDQM)/Council of Europe APEC Life Sciences Innovation Forum (LSIF) Training Program on Medical Product Integrity and Supply Chain Security Establishment of Global Single Point of Contact Systems- 28 January 2015, Clark (Angeles City), the Philippines Dr François-Xavier Lery, EDQM/Council of Europe
  • 2. Council of Europe Inter-governmental organisation Core values: • human rights • pluralist democracy • rule of law Distinct from European Union Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 3. European Directorate for the Quality of Medicines & HealthCare (EDQM) Council of Europe Directorate Convention on the Elaboration of a European Pharmacopoeia (1964) Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 4. Council of Europe/EDQM Specific platform for cooperation against counterfeit/falsified medical products: • Human Rights & Rule of Law • Minimising public health risks posed by counterfeit medical products & similar crimes Supported at the level of the EDQM by: Committee of Experts on Minimising public health risks posed by counterfeit medical products & similar crimes (expert & policy- making levels): CD-P-PH/CMED Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 5. CD-P-PH/CMED Support of promotion and application of the MEDICRIME convention by a comprehensive & integrated approach: • Support for the development of specific legislation • Multisectorial cooperation (EDQM training platform) & intelligence building→ SPOCs • Public health protection: awareness, risk communication, identification of health damage in patients Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 6. Drafted & presented: 2nd Workshop 22-23 May 2013, Seoul: EDQM, Lead, APEC RHSC Roadmap Working Group SPOC; inspired by Council of Europe SPOCs Model International Co-operation between National SPOCs National SPOC Role in international and national co-operation Central Reporting Point Industry Investigation SPOC e.g. Qualified/Responsible Person SPOC for Customs SPOC for Police SPOC for Justice SPOC for Medicines Regulatory Authority (DRA) incl. Official Medicines Control Laboratories Competent Authorities for Medical Devices national network SPOC Formal or informal collaboration between SPOCs at national level Signals Public; health professionals Overview: APEC SPOCs Tool Kit (1) Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 7. Overview of APEC SPOCs Tool Kit (2) → Scope: Medical products produced, marketed, advertised outside the regulatory control of the competent authorities (WHO SSFFC): criminal investigations on counterfeit/falsified medical products → Public health protection should be a priority → Cooperative approach: • A. National SPOC (one per state/economy) • B. SPOCs within competent authorities (a SPOC per competent authority in each state/economy) • Industry Investigation SPOC liaison/cooperation with A.,B. Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 8. Overview of APEC SPOCs Tool Kit (3) A. National SPOC – Central Reporting Point in one state/economy → Centralises information held by competent authorities within one state/economy about medical products produced, marketed, advertised outside the regulatory control of the competent authorities → Information is disseminated to National SPOCs of other states/economies for international cooperation Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 9. Overview of APEC SPOCs Tool Kit (4) B. SPOCs -police, customs, health authorities incl. official laboratories, judiciary- within one state/economy → Regular/systematic networking: law, agreement-based or informal → Operational management: « signals » (suspect cases) or confirmed cases → National authorities to decide on modes of investigation Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 10. APEC–EDQM/Council of Europe common goals (SPOCs) – common approaches (1) APEC LSIF Anti-counterfeit Medicines Action Plan Components – Council of Europe Model for a Network between SPOCs: 1. ...Cooperation within each APEC economy/states (regulators, customs, law enforcement, judicial and industry) critical… 2. APEC economies/states to work together to collect data on counterfeit medicines 3. APEC economies/states to coordinate legislation, penalties for prosecuting criminals counterfeiting medicines posing a threat to public health; bypassing regulatory control Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 11. APEC–EDQM/Council of Europe common goals (SPOCs) – common approaches (2) → Council of Europe SPOCs model: adopted June 2007 → European Union Regulatory Authorities (Working Party Enforcement Officers): endorsed September 2007 → Permanent Forum International Pharmaceutical Crime; tabled at WHO IMPACT endorsed December 2007 for international use → APEC Anti-counterfeit Medicines Action Plan: endorsed September 2010 (SPOCs: see previous slide) Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 12. APEC–EDQM/Council of Europe common goals (SPOCs) – common approaches (3) → Legal provisions for national/international cooperation among competent authorities: Council of Europe MEDICRIME Convention, international treaty: opened October 2011 for states to join → 2nd APEC LSIF Action Plan Workshop Seoul (Korea) May 2013: supported APEC SPOC Tool Kit → Agreed: development of National SPOC (within 12 months of APEC LSF and RHSC endorsement) Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 13. State of Play: Implementation of SPOCs EDQM basic training Aims: → raise awareness → foster co-operation → share knowledge & best practices – SPOCs model → in national teams (medical products regulators + police + customs) Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved. Activities: → delivery of training to nominees of authorities → trainers: delegates of Council of Europe bodies; → “train the trainers” approach: subsequent roll-out → evaluation: trainees’ feed-back – consideration in further basic/ advanced level training → follow up: immediately; impact 3 and 6 months after training
  • 14. State of Play: Implementation of SPOCs EDQM basic training Results: 2007 – ongoing National teams of 40 states in Europe; 6 States (Africa; South-America): 200 officials EDQM training platform Establishing/maintaining a network of SPOCs: Aims: Nomination/appointment/designation by national authorities: National SPOCs, authority SPOCs within 47 member states of Council of Europe Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 15. State of Play: Implementation of SPOCs – EDQM SPOC network Activities: National competent authorities notified (S)POCs or equivalents to the EDQM (2013) Results: National SPOCs, authority SPOCs (100): Regulatory, police, customs authorities; contact details, competencies, validity of authorisation EDQM to maintain list (based on procedure) Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 16. State of Play: Implementation of SPOCs – EDQM Advanced level SPOCs training Aim: → Knowledge, skills: to establish a SPOCs network and to co-operate across the region → Use of practical tools for SPOCs co-operation → Forum for exchange of expertise and experience Activities development: → Tracking sheets → Signal management procedures → Tools for information exchange Results: 2012 - ongoing National teams of 12 states (Europe); 4 States (Africa): 90 officials Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 17. State of Play: Implementation of SPOCs – EDQM KnowX database Knowledge database: inventory of experiences with confirmed cases Aim: → Platform for officials from competent authorities to build knowledge and intelligence (restricted access) → Help SPOCs report and share information → Use/access for SPOCs/equivalent officials: under participating authorities’ control Activities: → EDQM: technical development and host of the database Results: → Database launched: March 2014 Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 18. Legal provisions: Interagency cooperation (S)POCs Convention on the counterfeiting of medical products and similar crimes involving threats to public health (Council of Europe international treaty; treaty series 211): MEDICRIME Goal: → Prevent and combat above acts through a harmonised international legal framework, perspective of public health protection Objectives: → Protection of public health through criminalising acts threatening patient health → Patient protection → Promotion of cooperation among competent health and law enforcement authorities within each state + on international level Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 19. Legal provisions: Interagency cooperation (S)POCs MEDICRIME Specific provisions supporting cooperation among authorities: → Art 17. National measures of coordination, collaboration and information exchange: • … to ensure that national competent authorities exchange information and cooperate to prevent and combat…through points of contact • …receiving and collecting data → Art 22. International co-operation on prevention and other administrative measures: • …designate a national contact point …transmitting and receiving requests for information and/or cooperation with the fight against counterfeiting of medical products and similar crimes involving threats to public health…. Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 20. Follow-up Upon LIF and RHC endorsement of SPOCs toolkit (2013): → APEC economies: status update of development of a SPOC system within their economy → APEC Gap analysis: a) operational SPOCs, b) SPOCs in development, c) planned SPOC development, d) no planned SPOCs → Establishment of APEC SPOC database – assistance offered: • INTERPOL (May 2013 SPOC workshop); • EDQM (CoE) particularly in APEC economies that are Council of Europe members, observers and observers European Pharmacopoeia Commission • Complementing SPOCs in Europe → Planning a follow-up SPOC APEC workshop during 2015: • expertise from APEC economies with operational SPOCs, WHO, EDQM and Interpol. Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 21. Conclusion  Networking across borders only effective if based on common concepts, understanding and working methods: harmonised SPOCs approach – APEC 1/3/21, international community  EDQM (Council of Europe) welcomes global international cooperation  Criminals are networkers – let’s do better! Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.
  • 22. Thank-you for your attention! For more information: www.coe.int; www.edqm.eu 22 Dr François-Xavier Lery © 2015 EDQM, Council of Europe. All rights reserved.